No registrations found.
ID
Source
Health condition
The experience of nausea in the Emergency Department.
Keywords:
Isopropyl alcohol
IPA
Nausea
Emergency Department
Sponsors and support
Intervention
Outcome measures
Primary outcome
Time to treatment: the time in minutes between the detection of nausea by ED staff and the administration of the symptomatic treatment for nausea.
Secondary outcome
- Percentage of nauseous patients that are symptomatically treated
- Percentage of patients receiving conventional anti-emetics
- Cost of symptomatic treatment of nausea
- ED staff experiences with IPA inhalation therapy with use of questionaire
Background summary
Nausea is one of the most common complaints of patients in the Emergency Department (ED). Conventional anti-emetics have not proved to be superior to placebo in treating nausea on the ED. Recent randomized clinical trials demonstrated that aromatherapy with isopropyl alcohol (IPA) provides quick relief of nausea compared to placebo and ondansetron. To our
knowledge, no research exists addressing the practical consequences of the use of IPA in the ED. Our objective is to investigate the practical implications of IPA aromatherapy as the first-line therapy for nausea in the ED
Study objective
IPA as first-line therapy in the Emergency Department leads to:
- faster initiation of symptomatic treatment for nauseous patients
- more patients receiving symptomatic treatment for nausea
- a decrease in the use of conventional anti-emetics
- a decrease in cost of the symptomatic treatment of nauseous patients
Study design
End of implementation phase, expected in august 2018.
Intervention
This is an implementation trail aiming to study the practical aspects of the IPA as first-line therapy. In the first phase the current treatment with conventional anti-emetics will be studied. In the second phase IPA inhalation will be implemented as first line therapy.
Finally, after the implementation of IPA inhalation, a questionnaire will be sent to the ED staff in order to capture the practical experience of the staff with the use of IPA inhalation.
Inclusion criteria
All patients > 18 years who react positively to the following question: “Are you nauseous or do
you feel like throwing up or have to vomit?”
Exclusion criteria
- patients allergic to IPA
- patients with impaired ability to inhale nasally (severely nasally congested patients, facial trauma, congenital deformations, etc)
- patients that cannot be properly instructed (e.g. decreased level of consciousness)
- pregnant patients
- patients <18 years
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL7177 |
| NTR-old | NTR7368 |
| Other | METC VUMC : NH018.021 |